1. Home
  2. PRDO vs GLTO Comparison

PRDO vs GLTO Comparison

Compare PRDO & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

N/A

Current Price

$34.30

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo Galecto Inc.

GLTO

Galecto Inc.

HOLD

Current Price

$28.17

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
GLTO
Founded
1994
2011
Country
United States
Denmark
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
PRDO
GLTO
Price
$34.30
$28.17
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$42.00
$43.67
AVG Volume (30 Days)
519.1K
355.2K
Earning Date
05-22-2026
01-01-0001
Dividend Yield
1.74%
N/A
EPS Growth
10.50
N/A
EPS
2.42
N/A
Revenue
$581,296,000.00
N/A
Revenue This Year
$5.51
N/A
Revenue Next Year
$1.69
N/A
P/E Ratio
$14.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.87
$2.01
52 Week High
$38.02
$38.33

Technical Indicators

Market Signals
Indicator
PRDO
GLTO
Relative Strength Index (RSI) 63.38 51.77
Support Level $30.93 $24.53
Resistance Level $34.60 $32.86
Average True Range (ATR) 1.13 2.50
MACD 0.15 -0.30
Stochastic Oscillator 81.10 29.94

Price Performance

Historical Comparison
PRDO
GLTO

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: